Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

2-Year U.S. Treasury Note Continuous Contract $103.586 0.004 0.00% 5-Year U.S. Treasury Note Continuous Contract $107.984 0.078 0.07% 10-Year U.S. Treasury Note Continuous Contract $110.969 0.125 ...

Last week's survey by the British Potato Council revealed that we prefer mash to chips. So is this good news for our health? Nutritionally speaking, both mash and chips are good sources of energy ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Android 9.0, up to Android 12, One UI 4.1 ...